# Amass Brands: financial statements, quarterly

AMSS · Nasdaq · CIK 1851491 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amss.md) · [Financials](/companies/amss/financials.md) · [Filings](/companies/amss/filings.md) · [Insiders](/companies/amss/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amss/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $k | [4,341](/filings/0001575872-26-000451.md) | [5,505](/filings/0001575872-26-000579.md) | [4,149](/filings/0001575872-26-000451.md) | [5,593](/filings/0001575872-26-000579.md) |
| Cost of revenue | $k | [3,126](/filings/0001575872-26-000451.md) | [3,360](/filings/0001575872-26-000579.md) | [3,076](/filings/0001575872-26-000451.md) | [4,097](/filings/0001575872-26-000579.md) |
| Gross profit | $k | [1,215](/filings/0001575872-26-000451.md) | [2,145](/filings/0001575872-26-000579.md) | [1,073](/filings/0001575872-26-000451.md) | [1,496](/filings/0001575872-26-000579.md) |
| Research and development | $k | [0.0](/filings/0001575872-26-000451.md) | not reported | [0.0](/filings/0001575872-26-000451.md) | not reported |
| Operating income | $k | [(1,897)](/filings/0001575872-26-000451.md) | [(749)](/filings/0001575872-26-000579.md) | [(2,522)](/filings/0001575872-26-000451.md) | [(5,958)](/filings/0001575872-26-000579.md) |
| Interest expense | $k | [1,544](/filings/0001575872-26-000451.md) | [492](/filings/0001575872-26-000579.md) | [455](/filings/0001575872-26-000451.md) | [1,337](/filings/0001575872-26-000579.md) |
| Income tax | $k | [0.0](/filings/0001575872-26-000451.md) | not reported | [0.0](/filings/0001575872-26-000451.md) | not reported |
| Net income | $k | [(3,657)](/filings/0001575872-26-000451.md) | [(1,237)](/filings/0001575872-26-000579.md) | [(3,036)](/filings/0001575872-26-000451.md) | [(7,474)](/filings/0001575872-26-000579.md) |
| Diluted EPS | $ per share | [(1.21)](/filings/0001575872-26-000451.md) | [(0.40)](/filings/0001575872-26-000579.md) | [(0.87)](/filings/0001575872-26-000451.md) | [(0.69)](/filings/0001575872-26-000579.md) |
| Basic EPS | $ per share | [(1.21)](/filings/0001575872-26-000451.md) | [(0.40)](/filings/0001575872-26-000579.md) | [(0.87)](/filings/0001575872-26-000451.md) | [(0.69)](/filings/0001575872-26-000579.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [0.8](/filings/0001575872-26-000579.md) | [1.0](/filings/0001575872-26-000451.md) | [1.6](/filings/0001575872-26-000579.md) |
| Current assets | $m | not reported | not reported | not reported | [15.7](/filings/0001575872-26-000579.md) | [16.4](/filings/0001575872-26-000451.md) | [17.8](/filings/0001575872-26-000579.md) |
| Total assets | $m | not reported | not reported | not reported | [25.0](/filings/0001575872-26-000579.md) | [25.6](/filings/0001575872-26-000451.md) | [28.2](/filings/0001575872-26-000579.md) |
| Current liabilities | $m | not reported | not reported | not reported | [23.8](/filings/0001575872-26-000579.md) | [25.6](/filings/0001575872-26-000451.md) | [25.4](/filings/0001575872-26-000579.md) |
| Total liabilities | $m | not reported | not reported | not reported | [25.7](/filings/0001575872-26-000579.md) | [28.5](/filings/0001575872-26-000451.md) | [26.1](/filings/0001575872-26-000579.md) |
| Shareholders' equity | $m | [14.8](/filings/0001575872-26-000579.md) | [11.7](/filings/0001575872-26-000579.md) | [10.8](/filings/0001575872-26-000579.md) | [(3.0)](/filings/0001575872-26-000579.md) | [(5.3)](/filings/0001575872-26-000451.md) | [(1.3)](/filings/0001575872-26-000579.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(721)](/filings/0001575872-26-000451.md) | [(626) d](/filings/0001575872-26-000579.md) | [(1,800)](/filings/0001575872-26-000451.md) | [(4,332) d](/filings/0001575872-26-000579.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3.0](/filings/0001575872-26-000451.md) | [3.1](/filings/0001575872-26-000579.md) | [3.5](/filings/0001575872-26-000451.md) | [10.8](/filings/0001575872-26-000579.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,605,081 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001575872-26-000579.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.